VANCOUVER, BC, Aug. 15,
2024 /CNW/ -
TSX VENTURE COMPANIES
BULLETIN V2024-2468
BACKSTAGEPLAY INC. ("BP.H")
[formerly Backstageplay
Inc. ("BP")]
BULLETIN TYPE: Transfer and New
Addition to NEX, Symbol Change
BULLETIN DATE:
August 15, 2024
TSX Venture
Tier 2 Company
In accordance with TSX Venture Policy 2.5, the Company has not
maintained the requirements for a TSX Venture Tier 2 company.
Therefore, effective at the open on Monday, August 19, 2024, the Company's
listing will transfer to NEX, the Company's Tier classification
will change from Tier 2 to NEX, and the Filing and Service Office
will change from Vancouver to
NEX.
As of August 19, 2024, the Company
is subject to restrictions on share issuances and certain types of
payments as set out in the NEX policies.
The trading symbol for the Company will change from BP to
BP.H. There is no change in the Company's name, no change in
its CUSIP number and no consolidation of capital. The symbol
extension differentiates NEX symbols from Tier 1 or Tier 2 symbols
within the TSX Venture market.
The Company is classified as a 'Technology' company.
_______________________________________
BULLETIN V2024-2469
MAWSON FINLAND LIMITED
("MFL")
BULLETIN TYPE: New Listing-IPO-Shares
BULLETIN DATE: August 15, 2024
TSX Venture Tier 1 Company
Mawson Finland Limited's (the "Company") Initial Public Offering
("Offering") Prospectus dated July 19,
2024 has been filed with and accepted by TSX Venture
Exchange, and filed with and receipted on July 23, 2024, by the Securities Commission in
Ontario pursuant to the provisions
of the applicable Securities Acts and has been filed under
Multilateral Instrument 11-102 Passport System in Alberta, British
Columbia, Manitoba,
New Brunswick, Newfoundland and Labrador, Nova
Scotia, Prince Edward
Island and Saskatchewan.
The common shares of the Company will be listed and admitted to
trading on TSX Venture Exchange, on the effective date stated
below.
The gross proceeds received by the Company for the Offering were
$2,875,000, which includes
$375,000 following the exercise in
full by the agent of its over-allotment option (2,875,000 common
shares at $1.00 per share).
The Company is classified as "Gold and silver ore mining"
company (NAICS Number 21222).
Agent: Eight Capital
Agent's fee: A cash commission equal to 6% of the gross proceeds
of the Offering, including gross proceeds raised under the
over-allotment option and excluding proceeds that resulted from
subscriptions for 1,700,000 IPO Shares by select persons designated
by the Company on its President's List.
|
Over-Allotment
Option:
|
The Company had granted
an over-allotment option to the Agent, entitling the Agent to
purchase up to 15% of the Offering, at $1 per share, which was
exercised in full by the Agent.
|
|
|
|
Commence
Date:
|
At the opening
Monday, August 19, 2024, the Common shares will commence
trading on TSX Venture Exchange.
|
Corporate Jurisdiction: Ontario
Capitalization: Unlimited common shares with no par value of
which 19,050,235 common shares will be issued and outstanding after
the closing of the Offering.
Escrowed Shares: 2,068,000
Transfer Agent: Marrelli Trust Company Limited
Trading Symbol: MFL
CUSIP Number: 577756109
For further information, please refer to the Company's
Prospectus dated July 19, 2024.
Company Contact: Neil MacRae,
Executive Chairman
Company Address: 110 Yonge
Street, Suite 1601, Toronto,
Ontario, M5C 1T4
Company Phone Number: (778) 999-4653
Company E-mail Address: neil@mawsonfinland.com
_______________________________________
24/08/15 - TSX Venture Exchange
Bulletins
TSX VENTURE COMPANIES
BULLETIN V2024-2470
DELPHX CAPITAL MARKETS INC. ("DELX")
BULLETIN
TYPE: Private Placement-Non-Brokered
BULLETIN
DATE: August 15,
2024
TSX Venture Tier 2 Company
|
Financing Type:
|
Non-Brokered Private
Placement
|
|
Gross Proceeds:
|
$357,500.07
|
|
Offering:
|
3,972,223 Listed Shares
with 3,972,223 warrants
|
|
|
|
Offering Price:
|
$0.09 per Listed
Share
|
|
|
|
Warrant Exercise
Terms:
|
$0.25 per Listed Share
for a five-year period
|
|
|
|
Commissions in
Securities:
|
Shares
Warrants
|
|
Finders
(Aggregate)
N/A 38,889
|
|
|
|
Commission Terms: Each
non-transferable warrant is exercisable at $0.25 for a five-year
period
|
|
|
|
Disclosure:
|
Refer to the company's
news release(s) dated July 26, 2024, July 31, 2024.
|
_______________________________________
BULLETIN V2024-2471
GOLDGROUP MINING INC. ("GGA")
BULLETIN TYPE:
Resume Trading
BULLETIN DATE: August 15, 2024
TSX Venture Tier 2
Company
Effective at 5:00 a.m. PST,
August 15, 2024, shares of the
Company resumed trading, an announcement having been made.
_______________________________________
BULLETIN V2024-2472
KALO GOLD CORP. ("KALO")
BULLETIN TYPE:
Private Placement-Non-Brokered
BULLETIN DATE:
August 15, 2024
TSX Venture
Tier 2 Company
|
Financing Type:
|
Non-Brokered Private
Placement
|
|
Gross Proceeds:
|
$1,786,779.18
|
|
Offering:
|
59,559,306 Listed
Shares
|
|
|
|
Offering Price:
|
$0.03 per Listed
Share
|
|
|
|
Non-Cash
Commissions:
|
N/A
|
|
|
|
Public
Disclosure:
|
Refer to the company's
news releases dated June 10, 2024, July 22, 2024 and August 13,
2024.
|
_______________________________________
BULLETIN V2024-2473
KWESST MICRO SYSTEMS INC. ("KWE")
BULLETIN
TYPE: Private Placement-Brokered
BULLETIN
DATE: August 15,
2024
TSX Venture Tier 2 Company
|
Financing Type:
|
Brokered Private
Placement
|
|
|
|
Gross Proceeds:
|
US$5,588,396.92
|
|
|
|
Offering:
|
1,542,194 Listed
Shares
|
|
930,548 Pre-Funded
Warrants
|
|
2,472,742
Warrants
|
|
|
|
Offering Price:
|
US$2.26 per Listed
Share
|
|
US$2,259 per Pre-Funded
Warrant
|
|
|
|
Pre-Funded Warrant
Terms:
|
US$0.001 per Listed
Share, subject to blocker limits
|
|
|
|
Warrant Exercise
Terms:
|
US$2.66 per Listed
Share for a 5-year period, subject to blocker limits
|
|
|
|
Commission in
Securities:
|
ThinkEquity LLC
received 123,637 Warrants
|
|
|
|
Commission Terms:
|
Each non-transferable
warrant is exercisable at US$2.66 for a 5-year period
|
|
|
|
Disclosure:
|
Refer to the Company
news release dated July 19 and 21, 2023
|
_______________________________________
BULLETIN V2024-2474
LODE GOLD RESOURCES INC. ("LOD")
BULLETIN TYPE:
Private Placement-Non-Brokered
BULLETIN DATE:
August 15, 2024
TSX Venture
Tier 2 Company
|
Financing Type:
|
Non-Brokered Private
Placement
|
|
|
|
Gross Proceeds:
|
$461,340
|
|
|
|
Offering:
|
13,181,143 Listed
Shares with 13,181,143 warrants attached
|
|
|
|
Offering Price:
|
$0.035 per Listed
Share
|
|
|
|
Warrant Exercise
Terms:
|
$0.05 per warrant for a
2-Year Period, subject to an acceleration right.
|
|
|
|
Public
Disclosure:
|
Refer to the company's
news release(s) dated May 31, 2024 and July 15 2024.
|
_______________________________________
BULLETIN V2024-2475
MEDICURE INC. ("MPH")
BULLETIN TYPE:
Property-Asset or Share Purchase Agreement
BULLETIN
DATE: August 15,
2024
TSX Venture Tier 2 Company
TSX Venture Exchange has accepted for filing documentation
relating to an Asset Purchase Agreement dated June 24, 2024 (the "Agreement") among Medicure
International Inc. ("Medicure International", a wholly owned
subsidiary of the Company) and a non-arm's length party (the
"Vendor"). Pursuant to the Agreement Medicure International
acquired all the assets that relate to the business of developing
pyridoxal 5'-phosphate analogues ("P5P Analogues"), the processes
for preparation, compositions containing P5P Analogues and methods
of medical treatment containing P5P Analogues (the "Assets") from
the Vendor.
As consideration, Medicure International paid the Vendor a
$100,000 cash payment upon Closing.
Medicure International, upon meeting certain milestones related to
the P5P Analogues, shall pay future cash payments to the Vendor of:
(i) $500,000 upon filing its first
investigational new drug application; (ii) $250,000 upon filing its first new drug
application; and (iii) $500,000 upon
receiving U.S. NDA approval.
In addition, Medicure International shall pay to the Vendor 10%
of net proceeds received from any third party not affiliated to
Medicure International with respect to any transactions relating to
the Assets, including but not limited to: (i) the sale or transfer
of all or substantially all of the Assets to a third party
purchaser; (ii) any license to develop, commercialize, use, offer
for sale, sell, import, export or exploit P5P Analogues, up to a
maximum value payable to the Vendor of $20
million; and (iii) the sale of a U.S. Food and Drug
Administration priority review voucher obtained in connection with
the development of P5P Analogues.
In the event, the Company retains a contract research
organization to provide services related to the development of the
P5P Analogues, the Vendor will be entitled to tender a bid for such
services and the opportunity to match quotes provided by third
party organizations.
In the event, the Company does not file a first investigational
new drug application within 7 years from Closing, related to the
P5P Analogues (first of the milestones), the Vendor has the option
at any time after such date to repurchase the Assets from Medicure
International, at a price equal to the aggregate of all expenses
incurred by Medicure International in connection with the
development of P5P Analogues (but not exceeding USD$6.5 million), subject to prior Exchange
acceptance.
For further details, please refer to the Company's news release
dated June 24, 2024 and August 14, 2024.
_______________________________________
BULLETIN V2024-2476
MEDX HEALTH CORP. ("MDX")
BULLETIN TYPE:
Private Placement-Non-Brokered
BULLETIN DATE:
August 15, 2024
TSX Venture
Tier 2 Company
|
Financing Type:
|
Non-Brokered Private
Placement
|
|
|
|
Gross Proceeds:
|
$549,999.94
|
|
|
|
Offering:
|
7,857,142 Listed Shares
with 7,857,142 warrants attached
|
|
|
|
Offering Price:
|
$0.07 per Listed
Share
|
|
|
|
Warrant Exercise
Terms:
|
$0.12 per warrant until
December 31, 2026
|
|
|
|
Non-Cash
Commissions:
|
Shares
Warrants
|
|
Finders
(Aggregate)
N/A
N/A
|
|
|
|
Public
Disclosure:
|
Refer to the company's
news releases dated May 1, 2024, May 31, 2024, June 26, 2024 and
August 6, 2024.
|
_______________________________________
BULLETIN V2024-2477
PACIFIC IMPERIAL MINES INC. ("PPM")
BULLETIN
TYPE: Shares for Debt
BULLETIN DATE:
August 15, 2024
TSX Venture
Tier 2 Company
TSX Venture Exchange has accepted for filing the Company's
proposal to issue 3,682,906 common shares to settle outstanding
debt for $110,487.18.
Number of Creditors: 1 Creditor
Non-Arm's Length Party / Pro Group Participation: N/A
The Company shall issue a news release when the shares are
issued and the debt extinguished.
_______________________________________
BULLETIN V2024-2478
VIOR INC. ("VIO")
BULLETIN TYPE: Private
Placement-Brokered
BULLETIN DATE: August 15, 2024
TSX Venture Tier 2 Company
|
Financing Type:
|
Brokered Private
Placement
|
|
|
|
Gross Proceeds:
|
$21,833,000
|
|
|
|
Offering:
|
70,000,000 Listed
Shares
|
|
58,800,000 flow-through
Listed Shares
|
|
64,400,000
warrants
|
|
|
|
Offering Price:
|
$0.125 per Listed
Share
|
|
$0.2225 per
flow-through Listed Share
|
|
|
|
Warrant Exercise
Terms:
|
$0.21 per Listed Share
for a 2-year period
|
|
|
|
Commission in
Securities:
|
Eight Capital, PI
Financial Corp., Canaccord Genuity Corp., Red Cloud Securities
Inc., Cormark Securities Inc. and Leede Jones Gable Inc. received
in the aggregate 3,360,300 Warrants
|
|
|
|
Commission Terms:
|
Each non-transferable
warrant is exercisable at $0.21 for a 2-year period
|
|
|
|
Disclosure:
|
Refer to the Company
news release dated March 28, April 18 and June 28, 2024
|
VIOR INC. (« VIO »)
TYPE DE BULLETIN : Placement privé
par l'entremise d'un courtier
DATE DU BULLETIN : Le 15
août 2024
Société du groupe 2 de TSX Croissance
|
Type de financement
:
|
Placement privé par
l'entremise d'un courtier
|
|
|
|
Produit brut :
|
21 833 000 $
|
|
|
|
Placement :
|
70 000 000 action
inscrites
|
|
58 800 000 actions
inscrites accréditives
|
|
64 400 000 bons de
souscription
|
|
|
|
Prix offert :
|
0,125 $ par action
inscrite
|
|
0,2225 $ par action
inscrite accréditive
|
|
|
|
Modalités d'exercice
des
|
|
|
bons de souscription
:
|
0,21 $ par action
inscrite pour une période de 2 ans
|
|
|
|
Commission en titres
:
|
Eight Capital, PI
Financial Corp., Canaccord Genuity Corp., Red Cloud Securities
Inc., Cormark Securities Inc. et Leede Jones Gable Inc. ont reçu au
total 3 360 300 bons de souscription
|
|
|
|
Modalités des
commissions :
|
Chaque bon de
souscription non transférable permet de souscrire à une action au
prix d'exercice de 0,21 $ pendant une période de 2
ans
|
|
|
|
Communication de
l'information :
|
Se reporter aux
communiqués de presse de la société datés des 28 mars, 18 avril et
28 juin 2024
|
_______________________________________
BULLETIN V2024-2479
VIOR INC. ("VIO")
BULLETIN TYPE: Property-Asset or
Share Disposition Agreement
BULLETIN DATE: August 15, 2024
TSX Venture Tier 2
Company
TSX Venture Exchange (the "Exchange") has accepted for filing
with respect to the entering into a royalty agreement with a
non-arm's length party under which the Company has granted an
option for a 5-year period, subject to an acceleration clause, to
acquire for $5,000,000 in cash i) a
2% net smelter return royalty on its Belleterre Gold Property; and
ii) a right to cause the Company to fully exercise all buy-back
rights associated with existing royalties on the Belleterre Gold
Property and re-grant or transfer such royalties to the optionee.
The consideration for the option was $250,000 cash.
For further information, please refer to the Company's press
release dated March 28 and
June 28, 2024.
VIOR INC. (« VIO »)
TYPE DE BULLETIN :
Convention de vente de propriété d'actif ou
d'actions
DATE DU BULLETIN : Le 15 août
2024
Société du groupe 2 de TSX Croissance
La Bourse de croissance TSX (la « Bourse ») a accepté
le dépôt de documents relativement à la signature d'une entente de
royauté auprès d'une partie n'agissant pas à distance en vertu de
laquelle la société a octroyé une option d'une durée de 5 ans,
sujet à une clause d'accélération, visant l'acquisition pour une
somme de 5 000 000 $ en espèces de i) une redevance
de rendement net de fonderie sur sa propriété aurifère Belleterre ainsi que ii) un droit d'exiger que
la société exerce pleinement tous ses droits de rachat associée
avec les royautés en vigueur sur sa propriété aurifère Belleterre et de réoctroyer ou de transférer
ces royautés au titulaire de l'option. La considération pour
l'option était de 250 000 $ en espèces.
Pour plus d'information, veuillez-vous référer aux communiqués
de presse émis par la société les 28 mars et 28 juin 2024.
_______________________________________
BULLETIN V2024-2480
ZENTEK LTD. ("ZEN")
BULLETIN TYPE: Normal
Course Issuer Bid
BULLETIN DATE: August 15, 2024
TSX Venture Tier 2
Company
TSX Venture Exchange has been advised by the Company that
pursuant to a Notice of Intention to make a Normal Course Issuer
Bid dated August 14, 2024, it may
repurchase for cancellation, up to 5,084,319 common shares in its
own capital stock. The purchases are to be made through the
facilities of TSX Venture Exchange during the period from
August 16, 2024 to August 15, 2025. Purchases pursuant to the
bid will be made by Integral Wealth on behalf of the
Company.
_______________________________________
SOURCE TSX Venture Exchange